2. Anti-infection
  3. HCV
  4. HCV-IN-38

HCV-IN-38 is a potent, selective and orally active HCV inhibitor (EC50=15 nM, SI=431). HCV-IN-38 has high anti-HCV activity and low cytotoxicity. HCV-IN-38 has a good safety and oral pharmacokinetic profile.

For research use only. We do not sell to patients.

HCV-IN-38 Chemical Structure

HCV-IN-38 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

HCV-IN-38 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

HCV-IN-38 is a potent, selective and orally active HCV inhibitor (EC50=15 nM, SI=431). HCV-IN-38 has high anti-HCV activity and low cytotoxicity. HCV-IN-38 has a good safety and oral pharmacokinetic profile[1].

IC50 & Target

EC50: 15 nM (HCV) in Huh7.5 cells[1]
In Vitro

HCV-IN-38 (compound 80) (0-20 μM; 72 hours) exhibits high anti-HCV activity with EC50=15 nM and low cytotoxicity with CC50=6.47 μM in Huh7.5 cells[1].
HCV-IN-38 (2 μM; 2 hours) has moderate permeability (0.5 < Papp < 2.5 (×10-6 cm/s))[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

HCV-IN-38 Related Antibodies

Cell Cytotoxicity Assay

Cell Line: Huh7.5 cells[1]
Concentration: 0-20 μM
Incubation Time: 72 hours
Result: Exhibited low cytotoxicity with CC50=6.47 μM.
In Vivo

HCV-IN-38 (2 μM; 4 hours) has decent plasma stability (t1/2, rat=16.9 h and t1/2, human=19.9 h)[1].
HCV-IN-38 (2 mg/kg for i.p., 10 mg/kg for p.o., single) exhibits satisfying PK properties with an oral total exposure (AUC) of 1502 ng h/mL, medium in vivo clearance (38.3 mL/min/kg), Cmax of 452 ng/mL, and moderate bioavailability of 34%[1].
HCV-IN-38 (50-200 mg/kg; i.p., single) has modest safety profiles with LD50 values higher than 150 mg/kg[1].
Pharmacokinetic Parameters of HCV-IN-38 in Sprague-Dawley rats[1].

IV (2 mg/kg) PO (10 mg/kg)
AUC0-last (ng·h/mL) 889 ± 179 1502 ± 342
AUC0-inf (ng·h/mL) 898 ± 184 1525 ± 360
MRT0-last (h) 1.36 ± 0.182 2.95 ± 0.276
MRT0-inf (h) 1.45 ± 0.211 3.10 ± 0.290
Cmax (ng/mL) 452 ± 149
T1/2 (h) 1.24 ± 0.101 1.90 ± 0.492
Tlast (h) 8.00 12.0
Tmax (h) 1.00
Vdss (L/kg) 3.26 ± 0.426
Cl (mL/min/kg) 38.3 ± 8.89
F (%) 34

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: SD rats (180-220 g, n=3)[1]
Dosage: 2 or 10 mg/kg
Administration: i.v. and p.o., single (Pharmacokinetic Analysis)
Result: Exhibited satisfying PK properties with an oral total exposure (AUC) of 1502 ng h/mL, medium in vivo clearance (38.3 mL/min/kg), Cmax of 452 ng/mL, and moderate bioavailability of 34%.
Animal Model: Kunming mice (n=6)[1]
Dosage: 50, 100, 150, and 200 mg/kg
Administration: i.p., single
Result: Demonstrated modest safety profiles with LD50 values higher than 150 mg/kg.
Molecular Weight

500.90

Formula

C22H24ClF3N4O4
SMILES

CN(C1CN(C1)CC2=CC=C(C=C2C(F)(F)F)NC(C3=CC=C(C([N+]([O-])=O)=C3)OCCCl)=O)C
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

HCV-IN-38 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

HCV-IN-38HCVHepatitis C virusBiaryl amideOralSelectivityHuh7.5 cellsSD ratsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
HCV-IN-38
Cat. No.:
HY-115989
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

Request for HNMR Report

We have received your request and will respond to you as soon as possible.